Advertisement
Advertisement
U.S. markets open in 3 hours 58 minutes
Advertisement
Advertisement
Advertisement
Advertisement

SCYNEXIS, Inc. (SCYX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.1200-0.0200 (-0.93%)
At close: 04:00PM EDT
2.0500 -0.07 (-3.30%)
After hours: 07:04PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close2.1400
Open2.1300
Bid0.0000 x 900
Ask0.0000 x 1000
Day's Range2.0600 - 2.2100
52 Week Range1.8100 - 10.2500
Volume382,323
Avg. Volume319,506
Market Cap69.069M
Beta (5Y Monthly)2.05
PE Ratio (TTM)N/A
EPS (TTM)-1.2040
Earnings DateAug 15, 2022 - Aug 19, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est20.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for SCYX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • SCYNEXIS, Inc.
    Analyst Report: Merck & Co IncMerck & Co. is a worldwide pharmaceutical company. Its major drugs include treatments in oncology and diabetes. The company also has a leading vaccine business and an animal health division. MRK shares are included in the S&P 500.
    Rating
    Fair Value
    Economic Moat
    20 hours agoArgus Research
View more
Advertisement
Advertisement